Characteristics of the 71 pediatric patients
| Characteristic . | n/N . | % . |
|---|---|---|
| Time to relapse before CAR T-cell therapy, mo | ||
| ≥18 | 32 | 45 |
| <18 | 39 | 55 |
| Best response before CAR T-cell therapy | ||
| CR1 | 48 | 68 |
| CR2 | 15 | 21 |
| NR | 8 | 11 |
| Response after CAR T-cell therapy | ||
| CR1 | 45/48 | 94 |
| CR2 | 14/15 | 93 |
| NR | 7/8 | 88 |
| Characteristic . | n/N . | % . |
|---|---|---|
| Time to relapse before CAR T-cell therapy, mo | ||
| ≥18 | 32 | 45 |
| <18 | 39 | 55 |
| Best response before CAR T-cell therapy | ||
| CR1 | 48 | 68 |
| CR2 | 15 | 21 |
| NR | 8 | 11 |
| Response after CAR T-cell therapy | ||
| CR1 | 45/48 | 94 |
| CR2 | 14/15 | 93 |
| NR | 7/8 | 88 |
CR 2, second complete remission; NR, no response.